Table 4.
Composition | Antimicrobial Activity | Reference |
---|---|---|
Clarithromycin/DODAB/CMC | M. abscessus | [6] |
Amphotericin B/DODAB/CMC/PDDA | C. albicans | [7] |
PSS/DODAB/gramicidin D | E. coli, S. aureus | [10] |
Mesoporous silica/silver/antibiotic | E. coli, K. pneumoniae | [14] |
Porphirin photosensitizer/cholesterol/anti-tuberculosis pro-drug | M. fortuitum | [15] |
TAT amphiphilic peptide with hydrophobic cholesterol core |
MRSA, S. aureus, C. albicans, B. subtilis, C. neoformans |
[19] |
TAT amphiphilic peptide with palmitic acid core | MRSA, S. aureus, B. subtilis, E. coli, P. aeruginosa | [20] |
Amphotericin B/polyglutamic acid | C. albicans | [21] |
Cholesterol-conjugated cationic G3R6TAT peptides | C. neoformans | [44] |
PMMA/DODAB; PMMA/CTAB | S. aureus, P. aeruginosa | [60] |
Silver/carboxymethyl tamarind polysaccaride | E. coli, S. typhimurium, B. subtilis | [95] |
PLGA-PLH-PEG/vancomycin | S. aureus | [102] |
PMMA/PDDA | E. coli, S. aureus, C. albicans | [109] |
PLGA/hydrophobic gentamicin | S. aureus, L. monocytogenes | [116] |
Triblock copolymer PEO-b-PPO-b-PEO/gentamicin | S. typhimurium, L. monocytogenes | [117,118] |
N-halamine-silica-polyacrylamide | S. aureus, E.coli | [138] |
Polyisothioronium methylstyrene crosslinked by ethylene glycol dimethacrylate | P. aeruginosa, E. coli, S. aureus, L. innocua | [139] |
Hyperbranched poliamidoamine/N-diazoniumdiolate nitric oxide donors | Gram-negative and -positive periodontal and cariogenic bacteria | [140] |
Block copolymers/gold/N-diazoniumdiolate NO donors | P. aeruginosa | [144] |
TAT-PEG-b-cholesterol/ciprofloxacin | E. coli | [164] |
Peptide polymer consisting of valine and lysine residues | Streptococcus and several others | [171] |
Carbon/gold/nisin | E. coli, P. aeruginosa | [211] |
Poly-d-lactide/chitosan/temporin B peptide | S. epidermidis | [214] |
PSS: polystyrene sulfate; TAT: transcriptional activator YGRKKRRQRRR peptide; PLGA-PLH-PEG: poly(d,l-lactic-co-glycolic acid)-b-poly(l-histidine)-b-poly(ethylene glycol).